The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy.
Massimo BrecciaFrancesca ChiodiAurelio Pio NardozzaDiletta ValsecchiValentina PerroneDiego SangiorgiElisa GiacominiMaria Chiara RendacePaola CocoEleonora PremoliLuca Degli EspostiPublished in: Advances in therapy (2022)
This analysis in Italian real-life clinical practice reported economic expenditure for patients with CML in 2nd or ≥ 3rd lines with TKIs, mostly burdened by hospitalizations. Such clinical complexity suggests that further efforts are needed to improve the therapeutic management of later lines of CML.